Intellectual property related to ISVAC™ production and application is well protected

  • Russian patent on methods of ISVAC™ production and application is obtained
  • Expanded PCT patent application is prepared by Darby&Darby, reputed New York IP-law firm
  • Scientific report on ISVAC™ development and investigation is published in August 2009 in "Russian Biopharmaceutical Journal"
image.jpg

  • Russian patentū number RU2007108037 and RU2007138092

    Russian patent on methods of ISVAC™ production and application is obtained.

  • PCT patent application number WO2008109686

    Expanded PCT patent application (full text) is prepared by Darby&Darby Covers methods of ISVAC™ production and application, including hetero-virus trans-replicon system, biological nanoparticle ISVAC™, ISVAC™ pharmaceutical preparation for interferon induction in patients, ISVAC™ pharmaceutical preparation for B-cell stimulation in patients, method of hepatitis C treatment with ISVAC™ pharmaceutical preparation for interferon induction and more (total 70 claims)

  • Scientific publication

    Having strictly applied mindset and operating on limited budget, we keep low academic profile. Our first paper was published in August 2009 in "Russian Biopharmaceutical Journal".